Pleural Mesothelioma (Drug Study-2)
Targeted therapy: Targeted therapy drugs, such as bevacizumab and sorafenib, aim to block specific molecules involved in cancer growth and progression. These drugs are being evaluated in clinical trials to determine
their effectiveness in treating pleural mesothelioma.